Modern Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Sell
9,144
-234
-2% -$35.1K 0.02% 440
2026
Q1
$1.45M Sell
9,378
-663
-7% -$102K 0.02% 349
2025
Q4
$1.38M Buy
10,041
+163
+2% +$21.3K 0.03% 353
2025
Q3
$1.27M Buy
9,878
+342
+4% +$41.7K 0.03% 343
2025
Q2
$1.15M Buy
9,536
+1,781
+23% +$201K 0.03% 345
2025
Q1
$864K Buy
+7,755
New +$826K 0.03% 323
2024
Q4
Sell
-1,791
Closed -$206K 596
2024
Q3
$206K Buy
+1,791
New +$203K 0.01% 414

Other funds holding NVS

Modern Wealth Management's NVS Position: Q2 2026 in Review

Modern Wealth Management reduced its Novartis (NVS) stake by 2.5% in Q2 2026, selling an estimated $35.1K and leaving 9,144 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #440.

Modern Wealth Management first reported a position in NVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.45M in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Modern Wealth Management held 9,144 shares of Novartis worth $1.43M as of Q2 2026.
  • Modern Wealth Management sold 234 Novartis shares in Q2 2026, an estimated $35.1K.
  • Novartis made up 0.02% of Modern Wealth Management's portfolio in Q2 2026, its #440 holding.
  • Modern Wealth Management first reported a position in Novartis in Q3 2024 and has held it in 7 quarters since.
  • Modern Wealth Management's Novartis position peaked at $1.45M in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.